NEWS

New publication on B cell maturation after SARS-CoV-2 mRNA vaccination
09 May 2022

The first data from the DigiHero is now officially published in Frontiers in Immunology.

​

We tracked B cells from individuals participating in the DigiHero study through their vaccination series including a third "booster" shot.

​

The percentage of antigen experienced SARS-CoV-2-specific B cells was low after the first two vaccinations but evolved over months and increased steeply after boosting. The third vaccination mobilized not only naïve, but also antigen-experienced B cell clones into further rapid somatic hypermutation trajectories indicating increased affinity.

These findings may explain why the third, but not the primary vaccination series, offers some protection against immune-escape variants such as Omicron

​

For more info on the DigiHero trial click here.

​

​

​

Welcome Denis!
01 April 2022

The Binderlab welcomes its newest member Denis Owczarek!

​

Denis has lots of academic and industry experience in antibody discovery and production.

​

We are really happy that he will help us to develop new CAR T cells.

​

Happy new year 2022
01 January 2022

The Binderlab wishes all of you and your friends and families a happy new year and a good start into 2022!

​

​

We have some big plans and are looking forward for the things to come.

​

​

​

Meanwhile, we celebrate this with a little gift to ourseleves and finally launch this website.

​